119 related articles for article (PubMed ID: 8029806)
1. Influence of endothelium-derived relaxing factor on platelet function and hemostasis in vivo.
Houston DS; Buchanan MR
Thromb Res; 1994 Apr; 74(1):25-37. PubMed ID: 8029806
[TBL] [Abstract][Full Text] [Related]
2. Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of recurrent platelet activation.
Golino P; Cappelli-Bigazzi M; Ambrosio G; Ragni M; Russolillo E; Condorelli M; Chiariello M
Circ Res; 1992 Dec; 71(6):1447-56. PubMed ID: 1423938
[TBL] [Abstract][Full Text] [Related]
3. NG-nitro-L-arginine antagonizes endothelium-dependent dilator responses by inhibiting endothelium-derived relaxing factor release in the isolated rabbit heart.
Lamontagne D; Pohl U; Busse R
Pflugers Arch; 1991 Apr; 418(3):266-70. PubMed ID: 1649992
[TBL] [Abstract][Full Text] [Related]
4. Endogenous endothelium-derived relaxing factor inhibits platelet adhesion under whole blood flow conditions ex vivo.
Jen CJ; Chen CT; Chen H
Chin J Physiol; 1995; 38(3):147-51. PubMed ID: 8846723
[TBL] [Abstract][Full Text] [Related]
5. Endothelium-derived relaxing factor inhibits platelet adhesion to cultured porcine endocardial endothelium.
Siney L; Lewis MJ
Eur J Pharmacol; 1992 Dec; 229(2-3):223-6. PubMed ID: 1283374
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine.
Thiemermann C; Mustafa M; Mester PA; Mitchell JA; Hecker M; Vane JR
Br J Pharmacol; 1991 Sep; 104(1):31-8. PubMed ID: 1786515
[TBL] [Abstract][Full Text] [Related]
7. Impaired tissue perfusion after inhibition of endothelium-derived nitric oxide.
Pohl U; Lamontagne D
Basic Res Cardiol; 1991; 86 Suppl 2():97-105. PubMed ID: 1953621
[TBL] [Abstract][Full Text] [Related]
8. Roles of prostacyclin, EDRF and active oxygens in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.
Hirafuji M; Shinoda H
Br J Pharmacol; 1993 Jun; 109(2):524-9. PubMed ID: 8358552
[TBL] [Abstract][Full Text] [Related]
9. The effect of NG-nitro-L-arginine methyl ester upon basal blood flow and endothelium-dependent vasodilatation in the dog hindlimb.
White DG; Drew GM; Gurden JM; Penny DM; Roach AG; Watts IS
Br J Pharmacol; 1993 Mar; 108(3):763-8. PubMed ID: 8467362
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor.
Stork AP; Cocks TM
Br J Pharmacol; 1994 Dec; 113(4):1099-104. PubMed ID: 7889260
[TBL] [Abstract][Full Text] [Related]
11. Modulation of vasodilatation to levcromakalim by hypoxia and EDRF in the rabbit isolated ear: a comparison with pinacidil, sodium nitroprusside and verapamil.
Randall MD; Griffith TM
Br J Pharmacol; 1993 Jun; 109(2):386-93. PubMed ID: 8358541
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
Vargas HM; Cuevas JM; Ignarro LJ; Chaudhuri G
J Pharmacol Exp Ther; 1991 Jun; 257(3):1208-15. PubMed ID: 1646327
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1987 Sep; 92(1):181-7. PubMed ID: 3311265
[TBL] [Abstract][Full Text] [Related]
14. Effects of bradykinin in the rat isolated perfused heart: role of kinin receptors and endothelium-derived relaxing factor.
Baydoun AR; Woodward B
Br J Pharmacol; 1991 Jul; 103(3):1829-33. PubMed ID: 1657268
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.
Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Vane JR
Br J Pharmacol; 1992 Dec; 107(4):1001-7. PubMed ID: 1281716
[TBL] [Abstract][Full Text] [Related]
16. Effects of oxygen and exogenous L-arginine on EDRF activity in fetal pulmonary circulation.
McQueston JA; Cornfield DN; McMurtry IF; Abman SH
Am J Physiol; 1993 Mar; 264(3 Pt 2):H865-71. PubMed ID: 8456989
[TBL] [Abstract][Full Text] [Related]
17. Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery.
Crack P; Cocks T
Br J Pharmacol; 1992 Oct; 107(2):566-72. PubMed ID: 1384915
[TBL] [Abstract][Full Text] [Related]
18. Different patterns of release of endothelium-derived relaxing factor and prostacyclin.
Mitchell JA; de Nucci G; Warner TD; Vane JR
Br J Pharmacol; 1992 Feb; 105(2):485-9. PubMed ID: 1373103
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
Palmer RM; Ferrige AG; Moncada S
Nature; 1987 Jun 11-17; 327(6122):524-6. PubMed ID: 3495737
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide (EDRF) enhances the vasorelaxing effect of nitrendipine in various isolated arteries.
Günther J; Dhein S; Rösen R; Klaus W; Fricke U
Basic Res Cardiol; 1992; 87(5):452-60. PubMed ID: 1463429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
